Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV

Sarah T. WilkinsonDepartment of Pathology, University of Arizona, Tucson, AZ

Diane R. FernandezDepartment of Pathology, University of Arizona, Tucson, AZ

Shawn P. MurphyDepartment of Obstetrics and Gynecology, University of Rochester School of Medicine and Dentistry, Rochester, NY

Rita M. BrazielDepartment of Pathology, Oregon Health and Science University, Portland, OR

Elias CampoDepartment of Pathology, Hospital Clinic, University of Barcelona, Barcelona, Spain

Wing C. ChanDepartment of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE

Jan DelabieDepartment of Pathology, Radium Hospital, Oslo, Norway

Randy D. GascoyneDepartment of Pathology, British Columbia Cancer Agency, Vancouver, BC

Louis M. StaudtMetabolism Branch

Elaine S. JaffeHematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Andreas RosenwaldInstitue of Pathology, University of Würzburg, Würzburg, Germany

Lisa M. RimszaDepartment of Pathology, University of Arizona, Tucson, AZCorrespondence[email protected]

Your download is now in progress and you may close this window